Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jiangsu Cai Qin Technology
688182
5
Dalian Dalicap Technology
301566
US Stock MarketDetailed Quotes
SANA Sana Biotechnology
- 1.650
- +0.070+4.43%
Close Apr 17 16:00 ET
- 1.650
- 0.0000.00%
Post 18:09 ET
371.29MMarket Cap-1.42P/E (TTM)
1.660High1.580Low1.35MVolume1.610Open1.580Pre Close2.21MTurnover1.01%Turnover RatioLossP/E (Static)225.02MShares10.50052wk High1.48P/B221.30MFloat Cap1.26052wk Low--Dividend TTM134.12MShs Float44.600Historical High--Div YieldTTM5.06%Amplitude1.260Historical Low1.635Avg Price1Lot Size
About Sana Biotechnology Company
Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.
Company Profile
SymbolSANA
Company NameSana Biotechnology
Listing DateFeb 4, 2021
Issue Price25.00
Founded2018
CEODr. Steven D. Harr, M.D.
MarketNASDAQ
Employees194
Fiscal Year Ends12-31
Address188 East Blaine Street,Suite 400
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98102
Phone1-206-701-7914
Websitehttp://www.sana.com
Company Executives
- Name
- Position
- Salary
- Dr. Steven D. Harr, M.D.
- President, Acting Principal Financial Officer, Chief Executive Officer and Director
- 2.67M
- Christian Hordo
- Executive Vice President and Chief Business Officer
- --
- Susan Wyrick
- Acting Chief Financial Officer, Acting Treasurer, and Acting Principal Accounting Officer
- --
- Bernard J. Cassidy
- Executive Vice President, General Counsel and Corporate Secretary
- --
- Hans Edgar Bishop
- Chairman of the Board
- 354.80K
- Dr. Richard C. Mulligan, PhD
- Executive Vice Chairman of the Board
- --
- Michelle Seitz, C.F.A.
- Independent Director
- 314.80K
- Mary Agnes Wilderotter
- Independent Director
- 314.80K
- Robert Taylor Nelsen
- Independent Director
- 294.80K
- Dr. Patrick Y. Yang, PhD
- Independent Director
- 299.80K
- Dr. Joshua H. Bilenker, M.D.
- Independent Director
- 299.80K
- Dr. Douglas G. Cole, M.D.
- Independent Director
- 302.30K
- Dr. Alise S. Reicin, M.D.
- Independent Director
- 302.30K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
